Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab

OBJECTIVE: To determine whether patients with inflammatory autoimmune diseases treated with rituximab (RTX) have more severe forms of COVID-19 compared with patients treated with anticytokine therapies, such as Tumour Necrosis Factor (TNF) inhibitors. METHODS: We included all patients who were on ei...

Descripción completa

Detalles Bibliográficos
Autores principales: Melong Pianta Taleng, Cathy Mireille, Lauper, Kim, Gilbert, Benoit, Cunningham, Tim, Guemara, Romain, Brulhart, Laure, Dan, Diana, Courvoisier, Delphine, Finckh, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646967/
https://www.ncbi.nlm.nih.gov/pubmed/34862310
http://dx.doi.org/10.1136/rmdopen-2021-001711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646967/
https://www.ncbi.nlm.nih.gov/pubmed/34862310
http://dx.doi.org/10.1136/rmdopen-2021-001711

Ejemplares similares